SEC Form 4 · accession 0001127602-18-032917
GILEAD SCIENCES, INC. · GILD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John G McHutchison
Officer — Chief Scientific Off/HeadR&D
Period of report
Nov 10, 2018
Accepted (ET)
Nov 13, 2018 · 4:57 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000882095
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Nov 10, 2018 | M | 1,465 | — | A | 24,371 | D | |
| Common Stock | Nov 10, 2018 | F | 664 | $71.18 | D | 23,707 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitF1,F2 | — | Nov 10, 2018 | M | 1,465 | D | — | — | Common Stock | 1,465 | 1,465 | D |
Explanation of responses
- F1Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
- F2The restricted stock units have a four year vesting schedule. 25% vest on the anniversary of the date of grant until fully vested.